National Cancer Institute; Amended Notice of Meeting, 3888 [2025-00739]

Download as PDF 3888 Federal Register / Vol. 90, No. 9 / Wednesday, January 15, 2025 / Notices Dated: January 8, 2025. Bruce A. George, Program Analyst, Office of Advisory Committee Policy. [FR Doc. 2025–00690 Filed 1–14–25; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings lotter on DSK11XQN23PROD with NOTICES1 Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Emerging Technologies and Training Neurosciences Integrated Review Group; Imaging Technology for Neuroscience Study Section. Date: February 6–7, 2025. Time: 9:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Rachel A. Kane, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Dr., Bethesda, MD 20892, (301) 496–0221, email: kanera@ csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR Panel: Academic-Industrial Partnerships for Translation of Technologies. Date: February 11–12, 2025. Time: 8:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Address: The Watergate, 2650 Virginia Avenue NW, Washington, DC 20037. Meeting Format: Virtual Meeting. Contact Person: Jennifer Ann Sanders, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 496–3553, email: jennifer.sanders@nih.gov. Name of Committee: Applied Immunology and Disease Control Integrated Review Group; Transmission of Vector-Borne and Zoonotic Diseases Study Section. Date: February 11–12, 2025. VerDate Sep<11>2014 18:37 Jan 14, 2025 Jkt 265001 Time: 10:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Haruhiko Murata, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594–3245, email: muratah@ csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: January 10, 2025. Bruce A. George, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2025–00845 Filed 1–14–25; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Mental Health; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Mental Health Initial Review Group; Mental Health Services Study Section. Date: February 24–25, 2025. Time: 11:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. Meeting Format: Virtual Meeting. Contact Person: Aileen Schulte, Ph.D., Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Bethesda, MD 20852, 301–443– 1225, email: aschulte@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program No. 93.242, Mental Health Research Grants, National Institutes of Health, HHS) PO 00000 Frm 00102 Fmt 4703 Sfmt 4703 Dated: January 10, 2025. Bruce A. George, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2025–00843 Filed 1–14–25; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, TEP– 5B: SBIR Review Meeting, March 04, 2025, 11:00 a.m. to 04:00 p.m., National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W534, Rockville, Maryland, 20850 which was published in the Federal Register on December 26, 2024, FR Doc 2024– 30711, 89 FR 105062. This notice is being amended to change the virtual meeting date from March 04, 2025, 11:00 a.m. to 04:00 p.m. to March 03, 2025, 11:00 a.m. to 04:00 p.m. The meeting times, format, and location will stay the same. The meeting is closed to the public. Dated: January 8, 2025. David W. Freeman, Supervisory Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2025–00739 Filed 1–14–25; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Aging Special Emphasis Panel; Frontotemporal Lobar Degeneration. E:\FR\FM\15JAN1.SGM 15JAN1

Agencies

[Federal Register Volume 90, Number 9 (Wednesday, January 15, 2025)]
[Notices]
[Page 3888]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-00739]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the National 
Cancer Institute Special Emphasis Panel, TEP-5B: SBIR Review Meeting, 
March 04, 2025, 11:00 a.m. to 04:00 p.m., National Cancer Institute 
Shady Grove, 9609 Medical Center Drive, Room 7W534, Rockville, 
Maryland, 20850 which was published in the Federal Register on December 
26, 2024, FR Doc 2024-30711, 89 FR 105062.
    This notice is being amended to change the virtual meeting date 
from March 04, 2025, 11:00 a.m. to 04:00 p.m. to March 03, 2025, 11:00 
a.m. to 04:00 p.m. The meeting times, format, and location will stay 
the same. The meeting is closed to the public.

    Dated: January 8, 2025.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee 
Policy.
[FR Doc. 2025-00739 Filed 1-14-25; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.